Introducing Pharmacokinetic and Pharmacodynamic Concepts
- 19 October 2001
- book chapter
- Published by Taylor & Francis
- p. 32-63
- https://doi.org/10.1201/b14003-4
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- SERIOUS INTERACTION BETWEEN MIBEFRADIL AND TACROLIMUS1Transplantation, 1998
- Characterization of the Cytochrome P450 CYP2J4: Expression in Rat Small Intestine and Role in Retinoic Acid Biotransformation from RetinalArchives of Biochemistry and Biophysics, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4Biochemistry, 1997
- Pharmacokinetics of Selective Serotonin Reuptake Inhibitors: Clinical RelevanceBasic & Clinical Pharmacology & Toxicology, 1996
- The effects of selective serotonin reuptake inhibitors and their metabolites on S‐mephenytoin 4'‐hydroxylase activity in human liver microsomes.British Journal of Clinical Pharmacology, 1995
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactionsChemical Research in Toxicology, 1992
- PROTECTING POOR METABOLISERS, A GROUP AT HIGH RISK OF ADVERSE DRUG REACTIONSThe Lancet, 1983
- PHENFORMIN-INDUCED LACTICACIDOSIS ASSOCIATED WITH IMPAIRED DEBRISOQUINE HYDROXYLATIONThe Lancet, 1981